Aspirin 75mg gastro-resistant tablets

Land: Bretland

Tungumál: enska

Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)

Virkt innihaldsefni:

Aspirin

Fáanlegur frá:

DE Pharmaceuticals

ATC númer:

B01AC06

INN (Alþjóðlegt nafn):

Aspirin

Skammtar:

75mg

Lyfjaform:

Gastro-resistant tablet

Stjórnsýsluleið:

Oral

Tegund:

No Controlled Drug Status

Gerð lyfseðils:

Valid as a prescribable product

Vörulýsing:

BNF: 02090000

Upplýsingar fylgiseðill

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ASPIRIN 75MG GASTRO-RESISTANT TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This
medicine is available without prescription. However, you still need to
use Aspirin 75mg Gastro-Resistant Tablets carefully to get the best
results from it. Always take this medicine exactly as described in
this
leaflet or as your doctor or pharmacist has told you.
• Keep this leaflet. You may need to read it again.
• Ask your pharmacist if you need more information or advice.
• If you get any side effects, talk to your doctor or pharmacist.
This
includes any possible side effects not listed in this leaflet. See
section 4.
• You must talk to a doctor if you do not feel better or if you feel
worse
after three days.
WHAT IS IN THIS LEAFLET
1. What ASPIRIN 75MG GASTRO-RESISTANT TABLETS is and what it is
used for
2. What you need to know before you take ASPIRIN 75MG GASTRO-
RESISTANT TABLETS
3. How to take ASPIRIN 75MG GASTRO-RESISTANT TABLETS
4. Possible side effects
5. How to store ASPIRIN 75MG GASTRO-RESISTANT TABLETS
6. Contents of the pack and other information
1. WHAT ASPIRIN 75MG GASTRO-RESISTANT TABLETS IS AND WHAT
IT IS USED FOR
Aspirin belongs to a group of medicines called antiplatelet
agents that help prevent your blood cells sticking together and
forming a blood clot.
Aspirin 75mg Tablets are principally used to prevent blood clots
forming following a heart attack or stroke or to help prevent heart
attacks and strokes in patients who have previously suffered
from these conditions. They may have been prescribed for you if
you have recently had by-pass surgery.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ASPIRIN 75MG
GASTRO-RESISTANT TABLETS
Do not take Aspirin 75mg Gastro-Resistant Tablets:
• if you are allergic to aspirin or any of the other ingredients of
this medicine (listed in section 6)
• if you have ever had a bad reaction to aspirin or any other non-
steroidal anti-inflammatory med

Vara einkenni

OBJECT 1
ASPIRIN 75MG GASTRO-RESISTANT TABLETS
Summary of Product Characteristics Updated 25-Jul-2018 | Dexcel Pharma
Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Aspirin 75mg Gastro-Resistant Tablets
2. Qualitative and quantitative composition
Each tablet contains aspirin 75 mg.
Also includes 17mg/tablet lactose.
For the full list of excipients, see 6.1.
3. Pharmaceutical form
Gastro-resistant tablet.
White, film coated, round tablet.
4. Clinical particulars
4.1 Therapeutic indications
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular disease and following by-
pass surgery.
4.2 Posology and method of administration
Posology
_For the management of cardiovascular or cerebrovascular disease_:
Patients should seek the advice of a doctor before commencing therapy
for the first time.
The usual dosage, for long-term use, is 75-150mg once daily. In some
circumstances a higher dose may
be appropriate, especially in the short term, and up to 300mg a day
may